|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Three Discharge Modes of Dielectric Barrier Discharge in a Two-phase Mixture显示文摘两相体介质阻挡放电(dielectric barrier discharge in atwo-phase mixture,TPM-DBD)是在大气压下产生低温等离子体的重要方法,因具有很高的能量密度而被广泛应用在污染治理中。为研究介质颗粒的填充方式对TPM-DBD的影响,以γ-Al2O3作为填充介质颗粒,将数码相机与体视显微镜连体拍摄放电显微照片。结果发现,随着电压变化,TPM-DBD由3种依次串联发生的放电构成。电压较低时,首先在颗粒与极板间发生剩余间隙放电;随着电压增加,颗粒沿面放电串联发生;电压继续增加,孔隙放电串联发生。当颗粒间距较大时,在颗粒的远域出现典型的丝状放电,而近域内出现可能为汤森放电的放电"暗区"。外电场的数值计算结果初步说明了上述现象,电场畸变是其主要原因。研究结果为调节TPM-DBD的放电形式,进而高效率应用提供了较好的支持。 | CHEN Tian YE Qizheng TAN Dan YANG Fuli | 2012 | 中国电机工程学报2012，32，22： | 3 |
| 2 | Low-frequency HIFU induced cancer immunotherapy:tempting challenges and potential opportunities显示文摘Immunotherapy is playing an increasingly important role in the treatment of tumors.Different from the traditional direct killing or excision therapies,immunotherapy depends on autologous immunity to kill tumor cells and tissues by activating or enhancing the body's immune system.Large numbers of recent studies suggest that low-frequency HIFU can not only enhance the intensity of the body's anti-cancer immune response,but also improve the efficiency of immunotherapy drug delivery to strengthen the effects of tumor immunotherapy.The focused ultrasound(FUS)destructs the tumor and simultaneously generates tumor debris and tumor-associated antigens,which enhances the immunogenicity of the tumor and stimulates the immune cells,inducing the body's immune response.Microbubbles are clinically used as a contrast.As a matter of fact,the addition of microbubbles can reinforce the destructive effect of FUS on the tumor and activate a stronger immune response.The combined application of ultrasound and microbubbles can more effectively open the blood brain barrier(BBB),which is beneficial to improving the intake of immune cells or immunotherapy drugs and exerting a positive influence in the lesion area.Currently,microbubbles and nanoparticles are commonly used as gene and drug carriers.Using ultrasound,the immune-related gene or antigen delivery itself can enhance the immune response and improve the efficacy of the immunotherapy. | Guilian Shi Mingchuan Zhong Fuli Ye Xiaoming Zhang | 2019 | Cancer Biology & Medicine2019，16，4： | 3 |
| 3 | RNA-binding protein QKI regulates contact inhibition via Yes-associate protein in ccRCC显示文摘Contact inhibition adjusts organ size to the proper size and ensures the cultured cells growing to a monolayer.By regulating the downstream coordinator YAP,the evolutionarily conserved Hippo transduction pathway attunes cell growth and death in response to cell contact inhibition,polarity,self-renewal,and differentiation.Dysregulation of this pathway is involved in various diseases such as cancer.RNA-binding protein QKI regulates cell proliferation,metabolism,division,and immunity in various cancer models,but its role in cancer cell contact inhibition remains unclear.In this study,we aimed to clarify the relationship between QKI and YAP,and the role of their interaction in cell contact inhibition.We found a lower QKI expression level in sparse condition,whereas a higher expression level in confluent condition by western blot analysis and immunofluorescence assay.QKI knockdown elevated cell proliferation and invasion both in vitro and in vivo.Strikingly,the results of CCK-8 assay,colony formation assay,and transwell assay showed that the phenomenon was in accord with the expression level of pYAP and reverse with YAP.Higher levels of Wnt3a and β-catenin were also found in xenografts of QKI-knockdown clear cell renal cell carcinoma (ccRCC) CAKI-1 cells by western blot analysis and immumohistochemical staining.Finally,a positive correlation between QKI and pYAP was found in clinical specimens by immunohistochemistry.Thus,as a negative regulator of YAP,QKI attuned the cell contact inhibition,leading to inhibition of cancer cell proliferation and invasion through Wnt and GPCR pathway. | Zheng Zhu Di Wei Xi'an Li Fuli Wang Fei Yan Zibao Xing Zhao Yan Huanyu Lu Dongsheng Zhai Ziehen Ye Geng Zhang Ping Meng Yu Zheng Jiarui Yuan Zifan Lu Jianlin Yuan | 2019 | Acta Biochimica et Biophysica Sinica2019，51，1： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员